+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Primordial Dwarfism/ Dwarfism - Pipeline Insight, 2025 - Product Thumbnail Image

Primordial Dwarfism/ Dwarfism - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Single Ventricle Heart Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Single Ventricle Heart Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Urolithiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Urolithiasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
NETs Related Disease - Pipeline Insight, 2025 - Product Thumbnail Image

NETs Related Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
NGLY1 Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

NGLY1 Deficiency - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ocular GvHD - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular GvHD - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Overactive Bladder Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bladder Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Persistant Angina Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Persistant Angina Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Post Surgical Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Post Surgical Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Protein Degraders - Pipeline Insight, 2025 - Product Thumbnail Image

Protein Degraders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Refractive Errors - Pipeline Insight, 2025 - Product Thumbnail Image

Refractive Errors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Renal Impairment - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Impairment - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rotator Cuff Injuries - Pipeline Insight, 2025 - Product Thumbnail Image

Rotator Cuff Injuries - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Surgical Bleeding - Pipeline Insight, 2025 - Product Thumbnail Image

Surgical Bleeding - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Uremic Pruritus And Associated Dry Skin - Pipeline Insight, 2025 - Product Thumbnail Image

Uremic Pruritus And Associated Dry Skin - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vascular Anomalies- Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Anomalies- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Von Hippel-Lindau Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Von Hippel-Lindau Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more